GlucoTec, the Greenville, SC-based privately-held parent company of Glytec, LLC that has developed and deployed network-based systems for glycemic management under the trade name of G+™ Enterprise Edition, has completed a $8.27m Series A financing.
The round was led by Sea Dragon Healthcare Partners, L.P., with participation from Standard Pacific Capital Holdings LLLP.
The company intends to use the funds primarily to expand its direct US sales force, increase its international presence and advance research and development.
Led by Chairman Dr. Robert E. Fischell, GlucoTec offers real-time glycemic management systems for individualized dosage recommendations of insulin, glucose and saline, considering all pertinent patient information such as demographics, lab results, and risk factors.
The systems can be installed locally or operated remotely across the Internet.